Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kris Ylaya

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
The American Journal of Surgical Pathology|September 25, 2024
Expression of POU2F3 Transcription Factor and POU2AF2, POU2F3 Coactivator, in Tuft Cell-like Carcinoma and Other TumorsMaciej Kaczorowski, Kris Ylaya, Małgorzata Chłopek, et al.
Proteomics. Clinical Applications|December 8, 2010
Characterizations and validations of novel antibodies toward translational researchReginald Williams, Joon-Yong Chung, Kris Ylaya, et al.
The American Journal of Surgical Pathology|August 26, 2024
Immunohistochemical Evaluation of Schlafen 11 (SLFN11) Expression in Cancer in the Search of Biomarker-Informed Treatment Targets: A Study of 127 Entities Represented by 6658 TumorsMaciej Kaczorowski, Kris Ylaya, Małgorzata Chłopek, et al.
Veterinary Pathology|January 15, 2019
Immunophenotypic Characterization of Canine Splenic Follicular-Derived B-Cell LymphomaLeah Stein, Cynthia Bacmeister, Kris Ylaya, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 21, 2013
Downregulation of ERp57 expression is associated with poor prognosis in early-stage cervical cancerHyunsoo Chung, Hanbyoul Cho, Candice Perry, et al.
Pathology Oncology Research : POR|September 13, 2011
Wilms tumor-1, claudin-1 and ezrin are useful immunohistochemical markers that help to distinguish schwannoma from fibroblastic meningiomaAvninder Singh, Ashwani Kumar Mishra, Kris Ylaya, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|September 2, 2020
4-HNE Immunohistochemistry and Image Analysis for Detection of Lipid Peroxidation in Human Liver Samples Using Vitamin E Treatment in NAFLD as a Proof of ConceptMaren C Podszun, Joon-Yong Chung, Kris Ylaya, et al.
Endocrinology|June 18, 2010
Multiple endocrine neoplasia type 1 deletion in pancreatic alpha-cells leads to development of insulinomas in miceH-C Jennifer Shen, Kris Ylaya, Klaus Pechhold, et al.
Biopreservation and Biobanking|October 20, 2022
Quality Assessment of Proteins and RNA Following Storage in Archival Formalin-Fixed Paraffin-Embedded Human Breast Cancer Tissue Microarray SectionsKyungeun Kim, Kris Ylaya, Candice Perry, et al.
Anticancer Research|September 6, 2017
Bcl-2-like Protein 11 (BIM) Expression Is Associated with Favorable Prognosis for Patients with Cervical CancerBo Wook Kim, Hanbyoul Cho, Kris Ylaya, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
The American Journal of Surgical Pathology|September 25, 2024
Expression of POU2F3 Transcription Factor and POU2AF2, POU2F3 Coactivator, in Tuft Cell-like Carcinoma and Other TumorsMaciej Kaczorowski, Kris Ylaya, Małgorzata Chłopek, et al.
Proteomics. Clinical Applications|December 8, 2010
Characterizations and validations of novel antibodies toward translational researchReginald Williams, Joon-Yong Chung, Kris Ylaya, et al.
The American Journal of Surgical Pathology|August 26, 2024
Immunohistochemical Evaluation of Schlafen 11 (SLFN11) Expression in Cancer in the Search of Biomarker-Informed Treatment Targets: A Study of 127 Entities Represented by 6658 TumorsMaciej Kaczorowski, Kris Ylaya, Małgorzata Chłopek, et al.
Veterinary Pathology|January 15, 2019
Immunophenotypic Characterization of Canine Splenic Follicular-Derived B-Cell LymphomaLeah Stein, Cynthia Bacmeister, Kris Ylaya, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 21, 2013
Downregulation of ERp57 expression is associated with poor prognosis in early-stage cervical cancerHyunsoo Chung, Hanbyoul Cho, Candice Perry, et al.
Pathology Oncology Research : POR|September 13, 2011
Wilms tumor-1, claudin-1 and ezrin are useful immunohistochemical markers that help to distinguish schwannoma from fibroblastic meningiomaAvninder Singh, Ashwani Kumar Mishra, Kris Ylaya, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|September 2, 2020
4-HNE Immunohistochemistry and Image Analysis for Detection of Lipid Peroxidation in Human Liver Samples Using Vitamin E Treatment in NAFLD as a Proof of ConceptMaren C Podszun, Joon-Yong Chung, Kris Ylaya, et al.
Endocrinology|June 18, 2010
Multiple endocrine neoplasia type 1 deletion in pancreatic alpha-cells leads to development of insulinomas in miceH-C Jennifer Shen, Kris Ylaya, Klaus Pechhold, et al.
Biopreservation and Biobanking|October 20, 2022
Quality Assessment of Proteins and RNA Following Storage in Archival Formalin-Fixed Paraffin-Embedded Human Breast Cancer Tissue Microarray SectionsKyungeun Kim, Kris Ylaya, Candice Perry, et al.
Anticancer Research|September 6, 2017
Bcl-2-like Protein 11 (BIM) Expression Is Associated with Favorable Prognosis for Patients with Cervical CancerBo Wook Kim, Hanbyoul Cho, Kris Ylaya, et al.
Pageof 7